John M. Evans
CEO at Beam Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Beam Therapeutics Inc., 3 years.
Beam Therapeutics Inc.
Director · CEO
Chief executive roles
Beam Therapeutics Inc.
· CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 27, 2024 | Beam Therapeutics Inc. | Open-market sale | −60,000 | $24.50 | $1,470,000 |
| Apr 1, 2024 | Beam Therapeutics Inc. | Open-market sale | −18,102 | $32.13 | $581,617 |
| Mar 31, 2024 | Beam Therapeutics Inc. | Grant or award | +77,500 | — | — |
| Mar 28, 2024 | Beam Therapeutics Inc. | Open-market sale | −60,000 | $33.86 | $2,031,600 |
| Jan 31, 2024 | Beam Therapeutics Inc. | Open-market sale | −60,000 | $25.33 | $1,519,800 |
| Apr 4, 2023 | Beam Therapeutics Inc. | Open-market sale | −6,493 | $29.09 | $188,881 |
| Apr 3, 2023 | Beam Therapeutics Inc. | Open-market sale | −5,161 | $30.31 | $156,430 |
| Mar 31, 2023 | Beam Therapeutics Inc. | Grant or award | +56,250 | — | — |
| Mar 31, 2023 | Beam Therapeutics Inc. | Option exercise | +13,850 | $7.22 | $99,997 |
| Mar 6, 2023 | Beam Therapeutics Inc. | Small acquisition | +225 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.